Donna Doherty
Gerontology · New Hyde Park, NYNPI 1427669654
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 289 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,844 and has fallen 74.4% since, to $473 in 2025. Among gerontology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$732
- Merck$711
- Amgen$699
- Pfizer$421
- Boehringer Ingelheim$395
- Edwards Lifesciences$305
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,750100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 55 | $732 |
| Merck | 33 | $711 |
| Amgen | 28 | $699 |
| Pfizer | 36 | $421 |
| Boehringer Ingelheim | 15 | $395 |
| Edwards Lifesciences | 12 | $305 |
| Sanofi-aventis U.S. LLC | 12 | $280 |
| AbbVie | 5 | $251 |
| Regeneron Healthcare Solutions, Inc. | 6 | $160 |
| Esperion Therapeutics, Inc. | 6 | $140 |
| Inspire Medical Systems, Inc. | 6 | $139 |
| Harmony Biosciences LLC | 1 | $125 |
| Novartis | 6 | $119 |
| Scpharmaceuticals Inc. | 5 | $119 |
| Johnson & Johnson | 6 | $107 |
| Althera Pharmaceuticals LLC | 6 | $101 |
| Azurity Pharmaceuticals, Inc. | 6 | $101 |
| Novo Nordisk | 5 | $89 |
| Arbor Pharmaceuticals, Inc. | 5 | $87 |
| AstraZeneca | 5 | $82 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $72 |
| Actelion Pharmaceuticals US, Inc. | 2 | $66 |
| Heartflow, Inc. | 3 | $59 |
| Medtronic | 3 | $59 |
| Currax Pharmaceuticals LLC | 4 | $57 |
| Boston Scientific | 2 | $46 |
| Kestra Medical Technology Services, Inc. | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $34 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $33 |
| Cvrx, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Philips North America LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,750 in reported general payments places this provider in the 95th percentile of 187 gerontology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 114 | $138,864 |
| XareltoRivaroxaban | 67 | $74,543 |
| Repatha SureclickEvolocumab | 56 | $51,796 |
| MultaqDronedarone Hcl | 29 | $37,708 |
| EntrestoSacubitril/Valsartan | 27 | $28,393 |
| EdarbiAzilsartan Medoxomil | 36 | $21,182 |
| BrilintaTicagrelor | 18 | $15,268 |
| VascepaIcosapent Ethyl | 21 | $12,033 |
| BystolicNebivolol Hcl | 11 | $5,435 |
| Metoprolol Succinate | 203 | $3,485 |
| Rosuvastatin Calcium | 167 | $3,143 |
| Atorvastatin Calcium | 197 | $2,148 |
| Ranolazine ErRanolazine | 12 | $1,512 |
| Ezetimibe | 50 | $1,495 |
| Valsartan | 42 | $1,452 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $421 | $138,864114 claims |
| Johnson & JohnsonXarelto | $107 | $74,54367 claims |
| Sanofi-aventis U.S. LLCMultaq | $280 | $37,70829 claims |
| NovartisEntresto | $119 | $28,39327 claims |
| Arbor Pharmaceuticals, Inc.Edarbi | $87 | $21,18236 claims |
| AstraZenecaBrilinta | $82 | $15,26818 claims |
| Kowa Pharmaceuticals America, Inc.Bystolic | $14 | $5,43511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 187 gerontology providers in New York.
Other gerontology in New Hyde Park
- Edmund NeboNew Hyde Park$785
- Amy YatesRochester$23K
- Kristen BattiatoStaten Island$15K
- Kathy SimoneNew York$6K
- Laping XuNew York$6K
- Aslihan YurdaozRochester$5K
- Kennedy O'HaraUniondale$5K
- Dan Ai LiuNew York$5K
- Marceline CookPoughkeepsie$5K
- Sheila LekankaBuffalo$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.